Protein design of novel immunotherapeutic drugs
antibodies - gene therapy - vaccines - cellular therapies - peptides
Schoeder Lab
at Leipzig University, Medical Faculty, Institute for Drug Discovery
antibodies - gene therapy - vaccines - cellular therapies - peptides
at Leipzig University, Medical Faculty, Institute for Drug Discovery
Our Research Interests
We use computational protein design including machine learning to design proteins with new functionalities. Through interchanging application of computational protein design and experimental validation, we design a new generation of protein drugs.News from the lab!
Check below for some recent news from the lab.Great having you in Leipzig, Hope and Rachel from RosettaCommons
Hope Woods and Rachel Clune from RosettaCommons visisted us in Leipzig to inform us about the work RosettaCommons does to provide protein design tools stable and well-documented. We learned about the valuable ressources they host. Afterwards, taking Hope and Rachel out to dinner!Congratulations to your publication, Jakob and Sophia!
Great collaboration with Denise Kühnert and Richard Daodu from the Robert-Koch-Institute, structurally modelling the LASV GPC and understanding a deletion.Funding of the lab
We thank RosettaCommons, the state of Saxony, the Faculty of Medicine of Leipzig University, the Coalition for Epidemic Preparedness Innovations (CEPI), the ScaDS.AI and the DAAD for their contributions to our research.
We are part of the SFB1423 "Structural Dynamics of GPCR Signaling". Check it out here: research.uni-leipzig.de/sfb1423/
We are also part of SFB1664 "SNP2PROT - Plant Proteoform Diversity". Link to SNP2PROT
clara.schoeder[at]medizin.uni-leipzig.de
Leipzig University Medical FacultyInstitute for Drug DiscoveryLiebigstr. 19D-04103 Leipzig